Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation

Article Date
March 6, 2026

This article is featured on another website.

Go to article

Related posts

Browse all articles
March 13, 2026

Connect with HiRO at the 2026 AAD Annual Meeting

Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…

March 13, 2026

Connect with HiRO at the 2026 AAD Annual Meeting

Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…

March 26, 2026

Kainova Therapeutics to Present Clinical and Preclinical Updates on its GPCR Programs at AACR Annual Meeting 2026

March 26, 2026

Kainova Therapeutics to Present Clinical and Preclinical Updates on its GPCR Programs at AACR Annual Meeting 2026